
Zumutor Biologics
Operator of an immuno-oncology company intended to offer targeted cell therapeutics. The company develops diverse human antibody libraries to identify novel Immunotherapies and improved monoclonal ant...
Valuation
$42.6M
Latest known
Share Price
N/A
Total Raised
$29.1M
Last Round
N/A